Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2730-6011
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer ; volume:12 ; number:1 ; day:18 ; month:5 ; year:2021 ; pages:1-11 ; date:12.2021
Discover oncology ; 12, Heft 1 (18.5.2021), 1-11, 12.2021
- Creator
-
Caruso, Riccardo
Vicente, Emilio
Quijano, Yolanda
Duran, Hipolito
Fabra, Isabel
Diaz, Eduardo
Malave, Luis
Agresott, Ruben
Cañamaque, Lina García
Ielpo, Benedetto
Ferri, Valentina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-021-00405-w
- URN
-
urn:nbn:de:101:1-2021091721120920894774
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Caruso, Riccardo
- Vicente, Emilio
- Quijano, Yolanda
- Duran, Hipolito
- Fabra, Isabel
- Diaz, Eduardo
- Malave, Luis
- Agresott, Ruben
- Cañamaque, Lina García
- Ielpo, Benedetto
- Ferri, Valentina
- SpringerLink (Online service)
Other Objects (12)
The Relationship between Pathological Features and 18F-FDG PET/CT that Changed the Surgeon's Decision as Neoadjuvant Therapy in Breast Cancer
Baseline [18F]FDG PET/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy
Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT
Correction: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
Predicting pathological response of locally advanced breast cancer to neoadjuvant chemotherapy: comparing the performance of whole body 18F-FDG PETCT versus DCE-MRI of the breast
Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics
[18F]Fluoromisonidazole PET in rectal cancer
The Relationship between Pathological Features and 18F-FDG PET/CT that Changed the Surgeon's Decision as Neoadjuvant Therapy in Breast Cancer
Baseline [18F]FDG PET/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy
Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT
Correction: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
Predicting pathological response of locally advanced breast cancer to neoadjuvant chemotherapy: comparing the performance of whole body 18F-FDG PETCT versus DCE-MRI of the breast
Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics
[18F]Fluoromisonidazole PET in rectal cancer
The Relationship between Pathological Features and 18F-FDG PET/CT that Changed the Surgeon's Decision as Neoadjuvant Therapy in Breast Cancer
Baseline [18F]FDG PET/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy
Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
Isolated Rectal Metastases from Locally Advanced Carcinoma Prostate Detected by 18F-PSMA-1007 PET/CT
Correction: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
Predicting pathological response of locally advanced breast cancer to neoadjuvant chemotherapy: comparing the performance of whole body 18F-FDG PETCT versus DCE-MRI of the breast
Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics